Riskpilot← Back to searchSign inGet full accessGULLSMED STAMNÆSS AS
ASActiveOrg 912158756Spjelkavikvegen 58, 6010 ÅlesundRetail sale of watches and jewellery · NACE 4777Est. 201316 employees
Revenue 2024
NOK 14,8M
+30% vs 2023
EBITDA margin
8.5%
+348% vs 2023
Equity ratio
43.8%
Financial strength
Net profit 2024
NOK 839K
+945% vs 2023
| Revenue | NOK 14,8M | +30% |
| EBITDA | NOK 1,3M | +348% |
| Net profit | NOK 839K | +945% |
| Total assets | NOK 11,2M | +18% |
| Equity | NOK 4,9M | +0% |
| Employees | 16 | — |
Legal name
GULLSMED STAMNÆSS AS
Org number
912158756
Legal form
Aksjeselskap
NACE code
4777 · Retail sale of watches and jewellery
Founded
5. juli 2013
Share capital
NOK 1 500 000
Employees
16 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder og ett styremedlem i fellesskap.
Company purpose
Å drive handel med gullsmedvarer og klokker, samt alt som dermed står i forbindelse.
Address
Spjelkavikvegen 58, 6010 Ålesund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 9 748 | 10 734 | 11 437 | 11 373 | 14 799 |
| Staff expenses | −2 433 | −2 958 | −3 311 | −3 805 | −3 909 |
| EBITDA | 1 034 | 462 | 498 | 282 | 1 263 |
| Depreciation & amort. | −167 | −98 | −93 | −59 | −59 |
| EBIT | 868 | 364 | 405 | 223 | 1 204 |
| Net financials | −520 | −33 | −93 | −114 | −128 |
| Profit before tax | 347 | 330 | 312 | 109 | 1 076 |
| Tax | 77 | 75 | 69 | 29 | 237 |
| Net profit | 270 | 255 | 243 | 80 | 839 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 10 878 | 7 562 | 8 889 | 9 453 | 11 191 |
| Equity | 1 231 | 4 856 | 4 824 | 4 904 | 4 902 |
| Long-term debt | 7 220 | 35 | 26 | 29 | 29 |
| Short-term debt | 2 427 | 2 670 | 4 039 | 4 519 | 6 260 |
| Total debt | 9 647 | 2 705 | 4 065 | 4 549 | 6 289 |
EBITDA margin
8.5%
This company
15.8%
Market median
-46% vs market
20202024
Equity ratio
43.8%
This company
38.2%
Market median
+15% vs market
20202024
Return on equity
17.1%
This company
18.4%
Market median
+7% vs market
20202024
Net profit margin
5.7%
This company
8.1%
Market median
-30% vs market
20202024
Asset turnover
1.32×
This company
1.12×
Market median
+18% vs market
20202024
Debt / equity
1.28×
This company
0.62×
Market median
-106% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2026 | |
| Chairman | 2026 | |
| Chairman | 2020 | |
| Board of Directors | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Stamnæss Invest As
GULLSMED STAMNÆSS AS Board members of GULLSMED STAMNÆSS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sandra Yvonne Ervik | Board of Directors | 0 companies |
| Trine Tora Førde Stamnæss | Chairman | 0 companies |
| Vidar Breiteig | Chairman | 0 companies |
| Roger Longva Olsen | Board of Directors | 0 companies |